CER-001 Atherosclerosis Regression ACS Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Connie Keyserling, MS
Cerenis Therapeutics
Study Director - Stephen Nicholls, MD PhD
South Australian Health and Medical Research Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Concord Repatriation General Hospital
Concord, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Queen Elizabeth Hospital
Woodville South, South Australia, Australia
- Peninsula Heart Centre
Frankston, Victoria, Australia
- Epworth Research Institute
Richmond, Victoria, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Military Hospital
Budapest, Hungary
- Semmelweiss University
Budapest, Hungary
- University of Debrecen
Debrecen, Hungary
- Pándy Kálmán County Hospital
Gyula, Hungary
- County Hospital of Kecskemet
Kecskemét, Hungary
- University of Szeged
Szeged, Hungary
- Meander Medisch Centrum
Amersfoort, Netherlands
- Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands
- Scheper Ziekenhuis
Emmen, Netherlands
- Medisch Centrum Haaglanden
Leidschendam, Netherlands
- Canisius-Wilhelmina Hospital
Nijmegen, Netherlands
- Maasstad Hospital
Rotterdam, Netherlands
- Twee Steden Hospital (tilburg)
Tilburg, Netherlands
- Viecuri Medisch Centrum
Venlo, Netherlands
- Heart Center Research, Llc
Huntsville, Alabama, United States
- Va San Diego Healthcare System
San Diego, California, United States
- Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Torrance, California, United States
- Va Eastern Colorado Health Care System
Denver, Colorado, United States
- Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
- Cardiovascular Associates Research Llc
Covington, Louisiana, United States
- Cardiac and Vascular Research Center of Northern Michigan
Petoskey, Michigan, United States
- University of Missouri Health System
Columbia, Missouri, United States
- Buffalo Heart Group Llp
Buffalo, New York, United States
- Veterans Affairs Wny Healthcare System
Buffalo, New York, United States
- Novant Health Heart and Vascular Institute
Charlotte, North Carolina, United States
- South Oklahoma Heart Research, Llc
Oklahoma City, Oklahoma, United States
- Dallas Va Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2015
- Primary completion
- 30 Nov 2016
- Completion
- 31 Dec 2016
- Last update posted
- 11 Feb 2019
- Registered enrollment
- 301
- Registry id
- NCT02484378
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.